NetworkNewsBreaks Archive - Page 898 of 2161

TuesdayFeb 01, 2022 1:47 pm

NetworkNewsBreaks – BevCanna Enterprises Inc.’s (CSE: BEV) (OTCQB: BVNNF) (FSE:7BC) Leadership Position Recognized in Food and Beverage, Cannabis Products Categories

BevCanna Enterprises (CSE: BEV) (OTCQB: BVNNF) (FSE: 7BC), a diversified health and wellness beverage and natural products company, recently announced it had been named as one of the 101 Top Food and Beverage Startups and Companies in Canada by Best Startup Canada. In addition, BevCanna was also recognized as one of the Top 101 Cannabis Startups and Companies in Canada, among innovators and growth companies within the Canadian cannabis industry. A recent article quotes BevCanna CEO Marcello Leone as saying, “This recognition of our leadership position within both the food and beverage and the cannabis products categories validates our strategy…

TuesdayFeb 01, 2022 1:39 pm

NetworkNewsBreaks – SPYR Inc. (SPYR) Affiliate Unveils MagixBlock USB DataBlocker as Standalone Offering

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company, and its subsidiary, Applied Magix Inc., has made its MagixBlock USB DataBlocker product a standalone option. Applied Magix develops and resells Apple(R) ecosystem-compatible products specifically for IoT smart home and connected car markets. The MagixBlock USB DataBlocker product combines both USB-A and USB-C versions in a universal package. “While our customers primarily use the MagixBlock DataBlocker to prevent their car’s not-so-smart system from interfering with MagixDrive operations, many have asked to have MagixBlock made available separately,” said Applied Magix CEO Dr. Harald Zink in the press release. “This way our customers can use…

TuesdayFeb 01, 2022 1:32 pm

NetworkNewsBreaks – 2022 BTC Miami Conference Set the Stage for Innovations in the Blockchain Industry

Thousands of crypto enthusiasts attended The North American Bitcoin Conference (“TNABC”) in Miami (“BTC Miami”), where top speakers in the blockchain space covered topics ranging from NFTs to DeFi, new applications of cryptography and various investment strategies. The event, which is now recognized as one of the most attended and longest-running conferences in the industry, delivered yet another unforgettable experience. TNABC featured discussions on how to make smart contracts scalable, the future of crypto regulation and the significant possibilities of NFTs. This year’s event also launched crypto masterclasses where participants learned how to navigate and lead the transformation of the…

TuesdayFeb 01, 2022 1:15 pm

NetworkNewsBreaks – MCX Technologies Corporation (TSX.V: MCX) Announces US$2.5M Private Placement

MCX Technologies (TSX.V: MCX) today announced that it intends to complete a non-brokered private placement offering to raise gross proceeds up to US$2.5 million. According to the update, the offering will consist of issuing up to 20,000,000 common shares of the company, each at a price of US$0.10. MCX plans to use the proceeds for general working capital as the company transitions into developing Web 3.0 technologies and applications. Common shares issued under the offering are subject to customary hold periods and have not been and will not be registered under the United States Securities Act of 1933 and may…

TuesdayFeb 01, 2022 1:11 pm

NetworkNewsBreaks – GreenBox POS (NASDAQ: GBOX) to Present at Winter Wonderland – Best Ideas Virtual Investor Conference

GreenBox (NASDAQ: GBOX), an emerging and rapidly growing fintech company, today announced that management will present at the Winter Wonderland Virtual Conference — Best Ideas from the Buyside, which is slated to take place from Feb. 8-11, 2022. Chairman Ben Errez will host a virtual presentation and participate in one-on-one meetings throughout the event. Errez’s presentation is scheduled to begin at 4 p.m. ET on Tuesday, Feb. 8, at which time he will discuss GreenBox’s rapidly expanding blockchain based payment processing business, its upcoming stablecoin spin-off and its strategy to play an integral role in the digital payments landscape. Interested…

TuesdayFeb 01, 2022 12:56 pm

NetworkNewsBreaks – Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (OTC: CMNDF) to Host Third Event in Psychedelics for Alcoholism Series

Clearmind Medicine (CSE: CMND) (FSE: CWY0) (OTC: CMNDF) a psychedelic drug company, has announced the speaker for the third webinar in its Psychedelics for Alcoholism series. The company has invited addiction specialist and world-renowned author Dr. Gabor Maté to talk on the effects of Alcohol Use Disorder, addition and trauma. The webinar will also include information about Clearmind's patented portfolio as an effective treatment for the disorder. A retired Vancouver physician and a member of the Order of Canada, Maté has written several books with his most recent book — “The Myth of Normal: Trauma, Illness and Healing in a Toxic Culture” —…

TuesdayFeb 01, 2022 12:17 pm

NetworkNewsBreaks – Eat Well Investment Group Inc. (CSE: EWG) (OTC: EWGFF) Expands Distribution of Amara Organic Foods to H-E-B Stores

Eat Well Group (CSE: EWG) (OTC: EWGFF) and its majority-owned portfolio company, Amara Organic Foods, has increased its retail footprint. Amara’s organic, plant-based baby food is now available in some 200 HEB Grocery Company locations in Texas. H-E-B is one of the nation’s largest independently owned food retailers. The company will be carrying Amara’s two new baby food flavors: Peas, Corn & Carrots and Tropical Mango. HEB has been around for more than a century and is primarily located in Texas and Mexico. The company is ranked second, behind only Amazon, in dunnhumby’s Retailer Preference Index. Amara products are also…

TuesdayFeb 01, 2022 12:12 pm

NetworkNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) at the Forefront of Research Investigating Psilocybin Compound for Smoking Cessation

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders. Mydecine has announced that, in preparation for its FDA pre-Investigational New Drug (“IND”) meeting on Feb. 28, the company has submitted a pre-IND briefing package to the U.S. Food and Drug Administration (“FDA”) for a clinical study evaluating MYCO-001 in a structured smoking cessation treatment program. Principal Investigator Dr. Matthew Johnson, Ph.D., professor of psychiatry and behavioral sciences at Johns Hopkins University, will lead the study that will assess the safety and efficacy of psilocybin-assisted…

TuesdayFeb 01, 2022 12:05 pm

NetworkNewsBreaks – Lottery.com (NASDAQ: LTRY) Launches New Brand as Part of B2B Affiliate Marketing Strategy

Lottery.com (NASDAQ: LTRY, LTRYW), a leading technology company that is transforming how, where and when the lottery is played, today announced LotteryLink, an important branding initiative of its global B2B affiliate marketing. The branding is part of Lottery.com’s strategy to utilize highly recognizable and descriptive names and domains to reach its global digital audience and leverage the company’s strong affiliate marketing capabilities. In addition, the company recently launched B2C customer marketing campaigns that utilize multiple media channels, including targeted digital ads and search engine optimization, to reach new users. “We are aggressively working to grow our user base while maintaining…

TuesdayFeb 01, 2022 11:54 am

NetworkNewsBreaks – Biogen Inc. (NASDAQ: BIIB) Featured in Mizuho Securities Research Report

Biogen (NASDAQ: BIIB) was featured in a recent equity research report published by Mizuho Securities USA LLC. The report reads, “This morning, Biogen announced that has exercised its option to develop and commercialize Genentech’s (a wholly-owned member of the Roche Group, RHHBY, not covered) CD20xCD3 T-cell engaging bispecific antibody mosunetuzumab (mosu). While Biogen already has certain presence in the oncology space through its anti-CD20 collaboration with Genentech, today’s announced exercised option builds upon this — and should be incrementally value accretive — with mosu bearing ~$1Bn risk-adjusted WW peak sales according to consensus (Biogen will get low-to-mid 30% of operating profits…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks